November 29, 2023
Estoril, Portugal - October 29-31, 2023
The eagerly anticipated 6th International Conference on Acute Myeloid Leukemia (AML), "Molecular and Translational: Advances in Biology and Treatment," held in Estoril, Portugal, from October 29–31, 2023, proved to be a groundbreaking event at the forefront of AML research and treatment.
Conference Overview: Biannually, the ESH Conferences on AML have solidified their role as essential scientific and educational platforms, bridging the gap between molecular and biologic developments and how these translate to a clinical setting. The conference showcased rapid progress in novel technological, molecular, and immunologic approaches, providing fresh insights into AML biology and therapeutic perspectives.
Program Highlights: The cutting-edge program addressed various aspects of AML, including:
Educational Accreditation: The conference was granted approval for 18 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH), reinforcing its commitment to providing valuable educational content.
Key Topics Explored: The conference delved into critical topics, offering a comprehensive understanding of AML, including:
Learning Objectives Achieved: Participants at ESHAML2023 accomplished a range of learning objectives, such as:
In summary, ESHAML2023 succeeded in fostering collaboration, sharing knowledge, and advancing the understanding and treatment of AML. The conference left participants inspired and equipped with the latest insights, promising to impact the future of AML research and patient care.
Looking to receive the latest news, project updates, and new offerings?